S100A6 抗体
(S100 Calcium Binding Protein A6 (S100A6))
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in stimulation of Ca2+-dependent insulin release, stimulation of prolactin secretion, and exocytosis. Chromosomal rearrangements and altered expression of this gene have been implicated in melanoma. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| S100A6 抗体 (AA 1-90) | 人 | 小鼠 Monoclonal |
|
|
|
| S100A6 抗体 (AA 1-90) | 人 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 1-89) | 大鼠 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 18-90) | 人 | 小鼠 Monoclonal |
|
|
|
| S100A6 抗体 (AA 1-90) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| S100A6 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 1-89) | 小鼠 | 小鼠 Monoclonal |
|
|
|
| S100A6 抗体 (AA 37-67) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 15-70) | 人 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 1-91) | 人 | 小鼠 Monoclonal |
|
|
|
| S100A6 抗体 (AA 1-90) | 人 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 1-89) | 小鼠 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 1-90) | 人 | 小鼠 Monoclonal |
|
|
|
| S100A6 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 1-90) | 人 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 | 人 | 兔 Polyclonal |
|
|
|
| S100A6 抗体 (AA 18-90) | 人 | 小鼠 Polyclonal |
|
|
|
| S100A6 抗体 (AA 1-89) | 小鼠 | 大鼠 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
2 references - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6B5
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 1-90
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-90
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-89
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6D1
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 18-90
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-90
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 7D11
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB19141
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 37-67, C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
- 适用
- 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- A3
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-89
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 37-67
Primary Antibody
- ELISA (ELISA: 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 15-70
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6B5
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
- 抗原表位
- AA 1-91
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-90
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-89
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1-1
- 标记
- unconjugated
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 1-90
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-90
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 18-90
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- A3
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-89
Latest Publications for our S100A6 抗体
: "Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane." in: Nature communications, Vol. 6, pp. 8752, (2015) (PubMed).
: "Identification of novel molecular markers through transcriptomic analysis in human fetal and adult corneal endothelial cells." in: Human molecular genetics, Vol. 22, Issue 7, pp. 1271-9, (2013) (PubMed).
: "Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 1, pp. 523-32, (2013) (PubMed).
: "S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue." in: Molecular vision, Vol. 17, pp. 2263-71, (2011) (PubMed).
: "Immunobiological characterization of cancer stem cells isolated from glioblastoma patients." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 16, Issue 3, pp. 800-13, (2010) (PubMed).
: "S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer." in: The American journal of pathology, Vol. 177, Issue 2, pp. 586-97, (2010) (PubMed).
: "Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha." in: The Journal of biological chemistry, Vol. 283, Issue 44, pp. 30174-83, (2008) (PubMed).
: "The Ankrd2, Cdkn1c and calcyclin genes are under the control of MyoD during myogenic differentiation." in: Journal of molecular biology, Vol. 349, Issue 2, pp. 349-66, (2005) (PubMed).
: "Calcyclin, a Ca2+ ion-binding protein, contributes to the anabolic effects of simvastatin on bone." in: The Journal of biological chemistry, Vol. 279, Issue 20, pp. 21239-47, (2004) (PubMed).
: "Identification of novel molecular markers through transcriptomic analysis in human fetal and adult corneal endothelial cells." in: Human molecular genetics, Vol. 22, Issue 7, pp. 1271-9, (2013) (PubMed).
: "Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 1, pp. 523-32, (2013) (PubMed).
: "S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue." in: Molecular vision, Vol. 17, pp. 2263-71, (2011) (PubMed).
: "Immunobiological characterization of cancer stem cells isolated from glioblastoma patients." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 16, Issue 3, pp. 800-13, (2010) (PubMed).
: "S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer." in: The American journal of pathology, Vol. 177, Issue 2, pp. 586-97, (2010) (PubMed).
: "Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha." in: The Journal of biological chemistry, Vol. 283, Issue 44, pp. 30174-83, (2008) (PubMed).
: "The Ankrd2, Cdkn1c and calcyclin genes are under the control of MyoD during myogenic differentiation." in: Journal of molecular biology, Vol. 349, Issue 2, pp. 349-66, (2005) (PubMed).
: "Calcyclin, a Ca2+ ion-binding protein, contributes to the anabolic effects of simvastatin on bone." in: The Journal of biological chemistry, Vol. 279, Issue 20, pp. 21239-47, (2004) (PubMed).
Aliases for S100A6 抗体
S100 calcium binding protein A6 (S100A6) 抗体S100 calcium binding protein A6 (S100a6) 抗体
uncharacterized LOC618256 (LOC618256) 抗体
S100 calcium binding protein A6 (calcyclin) (S100a6) 抗体
2A9 抗体
5B10 抗体
CABP 抗体
CACY 抗体
Cacy 抗体
CALCYCLIN 抗体
PRA 抗体
S100A6 抗体
您还需要查找其他产品吗？
You are here:
